Abstract
Edoxaban, a reversible and direct inhibitor of factor Xa, is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).
| Original language | American English |
|---|---|
| Journal | Medscape |
| State | Published - Mar 2 2016 |
Keywords
- edoxaban
- embolism
- inhibitor
- nonvalvular atrial fibrillation (NVAF)
- stroke
Disciplines
- Medicine and Health Sciences
- Pharmacy and Pharmaceutical Sciences
Fingerprint
Dive into the research topics of 'Anticoagulation With Edoxaban: When to Worry'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS